跳至主要内容
临床试验/NCT03445689
NCT03445689已完成不适用

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

University of Miami1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2018年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Central chemoreceptor control of breathing function

研究概览

简要总结

Premature infants present with significant oxygenation instability in the form of frequent spontaneous episodes of hypoxemia during the first weeks after birth. These infants are also exposed to hyperoxemia.

The objective of this study is to determine the extent to which exposure to frequent episodes of hypoxemia and hyperoxemia in extreme premature infants during the early stages of their evolving lung disease is associated with altered maturation and function of their respiratory control system.

This study is part of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes Clinical Research Centers (CRC) (U01) cooperative program of the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

详细描述

Most extreme premature infants present with respiratory failure due to altered lung function compounded by breathing instability due to an immature respiratory control function.

Premature infants present with significant oxygenation instability in the form of frequent spontaneous episodes of hypoxemia during the first weeks after birth. As a result, these infants receive oxygen supplementation but this is often excessive and these infants are also exposed to hyperoxemia. The extent to which these episodes of hypoxemia or the exposure to hyperoxemia impact on the maturation and function of the control of breathing system in extreme premature infants during the evolving stages of their respiratory disease is unknown. This is a prospective study that will systematically evaluate such association in extreme premature infants.

The main objective of this study is to determine the extent to which exposure to frequent episodes of hypoxemia and hyperoxemia in extreme premature infants during the early stages of their evolving lung disease is associated with altered maturation and function of their respiratory control system.

This study is part of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in Respiratory Outcomes Clinical Research Centers (CRC) (U01) cooperative program of the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Premature infants born at 23 0/7- 28 6/7 weeks gestational age
  • Postnatal age up to equivalent to 36 weeks postmenstrual age
  • Requiring supplemental oxygen and/or receiving mechanical ventilation, CPAP, nasal ventilation or nasal cannula

排除标准

  • Severe congenital anomalies that may affect life expectancy or pulmonary or neurosensory development
  • Severe CNS pathology that may alter respiratory control function

结局指标

主要结局

Central chemoreceptor control of breathing function

时间窗: at 36 weeks corrected postmenstrual age

Ventilatory response to carbon dioxide

Peripheral chemoreceptor control of breathing function

时间窗: at 36 weeks corrected postmenstrual age

Ventilatory response to oxygen (Dejours test)

Change in peripheral chemoreceptor control of breathing function

时间窗: Change from 32 to 36 weeks postmenstrual age

Ventilatory response to oxygen (Dejours test)

Change in central chemoreceptor control of breathing function

时间窗: Change from 32 to 36 weeks postmenstrual age

Ventilatory response to carbon dioxide

次要结局

  • Ventilatory stability - Periodic breathing density(at 32 and 36 weeks corrected postmenstrual age)
  • Ventilatory stability - Apnea frequency(at 32 and 36 weeks corrected postmenstrual age)
  • Ventilatory stability - Time series analysis of inter-breath interval(at 32 and 36 weeks corrected postmenstrual age)
  • Apneic CO2 threshold during mechanical ventilation(at 32 and 36 weeks corrected postmenstrual age)
  • Mechanisms of episodic hypoxemia(at 32 and 36 weeks corrected postmenstrual age)
  • Apneic CO2 threshold in central apnea(at 32 and 36 weeks corrected postmenstrual age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nelson Claure

Associate Professor

University of Miami

研究点 (1)

Loading locations...

相似试验